Abstract:Background Inflammatory myopathies (IM) and Myasthenia gravis (MG) are two well-recognised and distinctive neuromuscular diseases. The association of myasthenia gravis (MG) and inflammatory myositis (IM) is rare and often only one of the diseases is diagnosed. The coexistence of MG and IM might be associated with thymoma. Even less common is the association of IM (polymyositis or dermatomyositis) and myasthenia gravis in the absence of thymoma. Objectives Here, we report a case series of 6 patients with concurrent MG and IM who were followed at the Neuromuscular Disease Unit (NMDU) at a tertiary referral centre in Vancouver, British Columbia. We also conducted literature review on clinical characteristics, diagnostic challenge and management of this condition. Methods In this study, we retrospectively examined patients seen at NMDU from 2004 to 2017 who had diagnosis of concurrent MG and IM. We reviewed medical records to assess their clinical presentations, laboratory findings, imaging studies and electrophysiological features. The data is presented descriptively. Results We identified 6 patients with MG-IM overlap. Three patients had simultaneous onset of MG and IM, 2 of whom presented with myasthenia crisis and fulminant myositis. In the other 3 patients, MG was the initial presentation and IM occurred 3–11 years after MG. Diagnosis of MG was confirmed with clinical features, electromyography and/or serology. All had symptoms of MG with predominant ocular or bulbar weakness. Among these 6 patients, 3 had underlying thymic pathology including two benign thymoma and one stage IV thymoma; all 3 patients had Acetylcholine Receptor (AChR) Antibody. Of the 3 patients with no thymic pathology by computed tomography (CT) or thymectomy, 1 had high positive AChR antibody and 2 were negative. Four patients had biopsies confirming the diagnosis of dermatomyositis or polymyositis. The other 2 patients declined biopsy; however, their MRI and EMG findings were consistent with IM. Only one patient had typical dermatomyositis rash. Among the 3 patients with underlying thymic pathology, thymoma were resected; all 3 were treated with high dose glucocorticoid, IVIG, and methotrexate with complete remission after 2 years. Of the 3 patients with no thymic pathology identified, one patient (AChR+) was in remission on mycophenolate and passed away from pancreatic cancer; two patients (AChR-) had refractory MG and IM, and both responded to rituximab. Conclusions In summary, this is one of the largest case series with MG-IM overlap with or without thymic pathology. It is very important to recognise such association and the different pattern of muscle involvement because therapies may be adjusted to treat both conditions. In patients with thymic pathology, conventional disease modifying agents, IVIG and glucocorticoid in addition to thymoma resection appear to be effective. In patients with refractory MG and myositis who were AChR negative, rituximab may be effective. Disclosure of Interest None declared

Upper Gastrointestinal (GI) Manifestations of Inflammatory Myositis: A Tale of Two Patients

Dermatomyositis-related intestinal dysmotility

Myositis as an Extraintestinal Manifestation of Ulcerative Colitis: A Case Report and Literature Review

A Retrospective Review of Clinical Characteristics and Risk Factors of Dysphagia in Patients with Dermatomyositis

Cricopharyngeal bar and dermatomyositis: A cause of rapidly progressive dysphagia

AB0777 Inflammatory Myositis Associated with Myasthenia Gravis with and Without Thymic Pathology: Case Series and Literature Review

Prompt response to rituximab in a patient with resistant polymyositis with complications of dysphagia and dysphonia: a case report

No Muscle Left Behind: Cardiac Arrest and Myocarditis in a Patient With Idiopathic Inflammatory Myopathy

Targeting Weakness With a Combination of Isotonic Exercises in Dermatomyositis With Polyneuropathy: A Case Report

Evolution of Seronegative Inflammatory Myositis to Dermatomyositis With Characteristic Cutaneous Features: A Case Report

Myocarditis and myositis/myasthenia gravis overlap syndrome induced by immune checkpoint inhibitor followed by esophageal hiatal hernia: A case report and review of the literature

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis

Presence of Multiple Autoimmune Antibodies Involved in Concurrent Myositis and Myocarditis and Myasthenia Gravis Without Thymoma: A Case Report

Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options

A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With Gastrointestinal Stromal Tumor

Idiopathic Inflammatory Myopathies: Clinical Approach and Management

Myositis Specific Autoantibodies: A Clinical Perspective

Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review

Concurrent inflammatory myopathy and myasthenia gravis with or without thymic pathology: A case series and literature review.

Clinical features of anti-mitochondrial M2 antibody-positive myositis: case series of 17 patients

Gastrointestinal involvement in neuromuscular disorders